Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid Therapy
The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Abstract
The safety of long-term inhaled corticosteroid therapy at commonly prescribed doses is an issue of growing concern to physicians and international regulatory bodies. This is so because long-term use of these drugs has become the mainstay of chronic asthma management and their introduction now is widely recommended in official treatment guidelines at the ‘mild persistent’ stage of asthma, where regular daily therapy is first begun. In addition to more frequent use of inhaled corticosteroids, there is a further trend to use higher doses of existing inhaler therapies and to use the newer and more potent compounds that have recently become available. At the same time as these developments have been taking place, there has not been a concurrent move to a more rigorous examination of the safety profile of these inhaled corticosteroid treatments – especially to assess their effects on the hypothalamic-pituitary-adrenal (HPA) axis. Most safety data with respect to HPA axis effects have been derived from testing methods that are limited in their ability to detect HPA system impairment and, more seriously, that can give the impression of functional integrity in the HPA axis when there may be moderate (or even greater) impairment. In this first part of a two-part review of the HPA axis effects of inhaled corticosteroids and of how these effects should be assessed, we examine the currently used and the currently available testing methodologies and also review the present state of knowledge concerning the structure and function of the HPA axis and the effects of its suppression. It is clear that there are state-of-the-art tests to assess in a discriminating manner the safety profile of inhaled corticosteroids. These tests have been insufficiently employed, including during the drug development process, yet they are readily available, relatively inexpensive and can detect adrenal suppression before the appearance of clinical effects. In part 2 of this review we examine what can be learned about the effects of inhaled corticosteroid therapy on the HPA axis from the limited amount of reliable published information from clinical and pharmacological studies describing their use and safety.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689
Self-citationGuidelines for the diagnosis and management of asthma.
Solomon, P. A. (1992) · PubMed · Cited by 2,004
Efficacy and Safety of Inhaled Corticosteroids: New Developments
BARNES, P. J., PEDERSEN, S., & BUSSE, W. W. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.157315 · Cited by 749
Inhaled Glucocorticoids for Asthma
Barnes, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503303321307 · Cited by 629
Clinical review 62: Laboratory assessment of adrenal insufficiency.
Grinspoon, S. K., & Biller, B. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962298 · Cited by 442
Schlaghecke, R., Kornely, E., Santen, R. T., & Ridderskamp, P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260403 · Cited by 381
The assessment and treatment of asthma: A conference report
Hargreave, F. E., Dolovich, J., & Newhouse, M. T. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90056-a · Cited by 377
Risk of Fatal and Near-Fatal Asthma in Relation to Inhaled Corticosteroid Use
Ernst, P. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490240070039 · Cited by 308
Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid.
Ryrfeldt, Å., Andersson, P., Edsbäcker, S., Tönnesson, M., Davies, D., & Pauwels, R. (1982) · PubMed · Cited by 301
Adverse effects of inhaled corticosteroids
Hanania, N. A., Chapman, K. R., & Kesten, S. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80404-5 · Cited by 294
Cited by
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1218 · Cited by 456
Skoner, D. P., Rachelefsky, G. S., Meltzer, E. O., Chervinsky, P., Morris, R. M., Seltzer, J. M., Storms, W. W., & Wood, R. A. (2000) · Pediatrics · doi:10.1542/peds.105.2.e23 · Cited by 306
Woodcock, T., Barker, P., Daniel, S., Fletcher, S., Wass, J. A. H., Tomlinson, J. W., Misra, U., Dattani, M., Arlt, W., & Vercueil, A. (2020) · Anaesthesia · doi:10.1111/anae.14963 · Cited by 163
“Inhaled corticosteroid therapy is very common, and although it has been claimed not to endanger the functioning of the hypothalamo–pituitary–adrenal axis when administered within recommended dose ranges, recent evidence has shown that suppression of the adrenal response to ACTH is common [4, 15, 16].”
BackgroundGlucocorticoids and Inflammation Revisited: The State of the Art
Franchimont, D., Kino, T., Galon, J., Meduri, G. U., & Chrousos, G. (2002) · Neuroimmunomodulation · doi:10.1159/000069969 · Cited by 132
Self-citationLung function and asthma control with beclomethasone and formoterol in a single inhaler
Huchon, G., MAGNUSSEN, H., Чучалин, А. Г., Dymek, L., Bonnet-Gonod, F., & Bousquet, J. J. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.09.002 · Cited by 139
Metadata
- Authors
- Chrousos, G. P., & Harris, A. G.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Harris, Alan G.
- Venue
- Neuroimmunomodulation
- Publisher
- S. Karger AG
- Published
- 1998
- Volume
- 5
- Issue
- 6
- Pages
- 277-287
- ISSN
- 1021-7401 (ISSN-L)
- 1423-0216
- OpenAlex
- W2048065046
- Cited by
- 50
- References
- 90
- Citations by year
- 2026: 1 · 2024: 1 · 2023: 1 · 2020: 2 · 2016: 1 · 2015: 1 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- NeuroImmunoModulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- hypothalamic-pituitary-adrenal axis, inhaled corticosteroids, adrenal suppression, persistent asthma, drug safety, glucocorticoid adverse effects, mild persistent asthma
- MeSH terms
- Administration, Inhalation, Adrenal Cortex Hormones, Asthma, Humans, Hypothalamo-Hypophyseal System, Immunosuppression Therapy, Pituitary-Adrenal System, Neuroimmunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid Therapy. https://app.cochat.ai/papers/10.1159/000026348
- The paper
- Chrousos, G. P., & Harris, A. G. (1998). Hypothalamic-Pituitary-Adrenal Axis Suppression and Inhaled Corticosteroid Therapy. Neuroimmunomodulation. https://doi.org/10.1159/000026348
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.